BRIEF — Mankind Pharma Says To Buy 70% Majority Stake In Armed Cell Therapeutics Through Unit
Oct 15 (Reuters) — Mankind Pharma Ltd: Mankind Pharma - To Buy 70% Majority Stake In Armed Cell Therapeutics Through Subsidiary Mankind Pharma - Approves Additional Investment In Unit, Limit Now To Eur 50 Million Mankind Pharma - To Invest Eur 48 Million For 70% Stake In Armed Cell Therapeutics Source text:... Further